Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert G Webster

Showing results (51-60 of 314) with videos related to

Pageof 32
Sort By:
Vaccine|August 7, 2002
Eight-plasmid system for rapid generation of influenza virus vaccinesErich Hoffmann, Scott Krauss, Daniel Perez, et al.
Antimicrobial Agents and Chemotherapy|November 25, 2004
Neuraminidase inhibitor-rimantadine combinations exert additive and synergistic anti-influenza virus effects in MDCK cellsElena A Govorkova, Hong-Bin Fang, Ming Tan, et al.
Frontiers in Immunology|November 22, 2021
Tissue Specific Transcriptome Changes Upon Influenza A Virus Replication in the DuckLee K Campbell, Ximena Fleming-Canepa, Robert G Webster, et al.
The Journal of Infectious Diseases|July 20, 2005
Virulence may determine the necessary duration and dosage of oseltamivir treatment for highly pathogenic A/Vietnam/1203/04 influenza virus in miceHui-Ling Yen, Arnold S Monto, Robert G Webster, et al.
Drugs|July 10, 2010
Drugs in development for influenzaDavid A Boltz, Jerry R Aldridge, Robert G Webster, et al.
Virology|May 30, 2002
Reassortment and interspecies transmission of North American H6N2 influenza virusesRichard J Webby, Peter R Woolcock, Scott L Krauss, et al.
Plos Medicine|June 26, 2009
What is the optimal therapy for patients with H5N1 influenza?Nicholas J White, Robert G Webster, Elena A Govorkova, et al.
Journal of Virology|August 28, 2004
Molecular determinants within the surface proteins involved in the pathogenicity of H5N1 influenza viruses in chickensDiane J Hulse, Robert G Webster, Rupert J Russell, et al.
Antiviral Research|March 7, 2006
Combination chemotherapy, a potential strategy for reducing the emergence of drug-resistant influenza A variantsNatalia A Ilyushina, Nicolai V Bovin, Robert G Webster, et al.
The Journal of Infectious Diseases|February 28, 2002
Accumulation of defective neuraminidase (NA) genes by influenza A viruses in the presence of NA inhibitors as a marker of reduced dependence on NAMarina S Nedyalkova, Frederick G Hayden, Robert G Webster, et al.
Pageof 32

Showing results (51-60 of 314) with videos related to

Sort By:
Pageof 32
Vaccine|August 7, 2002
Eight-plasmid system for rapid generation of influenza virus vaccinesErich Hoffmann, Scott Krauss, Daniel Perez, et al.
Antimicrobial Agents and Chemotherapy|November 25, 2004
Neuraminidase inhibitor-rimantadine combinations exert additive and synergistic anti-influenza virus effects in MDCK cellsElena A Govorkova, Hong-Bin Fang, Ming Tan, et al.
Frontiers in Immunology|November 22, 2021
Tissue Specific Transcriptome Changes Upon Influenza A Virus Replication in the DuckLee K Campbell, Ximena Fleming-Canepa, Robert G Webster, et al.
The Journal of Infectious Diseases|July 20, 2005
Virulence may determine the necessary duration and dosage of oseltamivir treatment for highly pathogenic A/Vietnam/1203/04 influenza virus in miceHui-Ling Yen, Arnold S Monto, Robert G Webster, et al.
Drugs|July 10, 2010
Drugs in development for influenzaDavid A Boltz, Jerry R Aldridge, Robert G Webster, et al.
Virology|May 30, 2002
Reassortment and interspecies transmission of North American H6N2 influenza virusesRichard J Webby, Peter R Woolcock, Scott L Krauss, et al.
Plos Medicine|June 26, 2009
What is the optimal therapy for patients with H5N1 influenza?Nicholas J White, Robert G Webster, Elena A Govorkova, et al.
Journal of Virology|August 28, 2004
Molecular determinants within the surface proteins involved in the pathogenicity of H5N1 influenza viruses in chickensDiane J Hulse, Robert G Webster, Rupert J Russell, et al.
Antiviral Research|March 7, 2006
Combination chemotherapy, a potential strategy for reducing the emergence of drug-resistant influenza A variantsNatalia A Ilyushina, Nicolai V Bovin, Robert G Webster, et al.
The Journal of Infectious Diseases|February 28, 2002
Accumulation of defective neuraminidase (NA) genes by influenza A viruses in the presence of NA inhibitors as a marker of reduced dependence on NAMarina S Nedyalkova, Frederick G Hayden, Robert G Webster, et al.
Pageof 32